Annual Interest Coverage Ratio
N/A
31 December 2023
Summary:
Adaptimmune Therapeutics annual interest coverage ratio is not available.ADAP Interest Coverage Ratio Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Interest Coverage Ratio
-14.14
-148.31-110.54%
30 September 2024
Summary:
Adaptimmune Therapeutics quarterly interest coverage ratio is currently -14.14, with the most recent change of -148.31 (-110.54%) on 30 September 2024. ADAP quarterly interest coverage ratio is now -110.54% below its all-time high of 134.17, reached on 30 June 2024.ADAP Quarterly Interest Coverage Ratio Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ADAP Interest Coverage Ratio Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | - |
| 3 y3 years | - | - |
| 5 y5 years | - | - |
ADAP Interest Coverage Ratio High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -110.5% | at low | ||
| 5 y | 5 years | -110.5% | at low | ||
| alltime | all time | -110.5% | at low |
Adaptimmune Therapeutics Interest Coverage Ratio History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | -14.14(-110.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2024 | - | 134.17 |
| June 2013 | -1530.66 | - |
FAQ
- What is the all time high annual interest coverage ratio for Adaptimmune Therapeutics?
- What is Adaptimmune Therapeutics quarterly interest coverage ratio?
- What is the all time high quarterly interest coverage ratio for Adaptimmune Therapeutics?
What is the all time high annual interest coverage ratio for Adaptimmune Therapeutics?
Adaptimmune Therapeutics all-time high annual interest coverage ratio is -1530.66
What is Adaptimmune Therapeutics quarterly interest coverage ratio?
The current quarterly interest coverage ratio of ADAP is -14.14
What is the all time high quarterly interest coverage ratio for Adaptimmune Therapeutics?
Adaptimmune Therapeutics all-time high quarterly interest coverage ratio is 134.17